Free Trial
→ I was wrong about Trump (From Porter & Company) (Ad) Free TENX Stock Alerts

Tenax Therapeutics (TENX) Short Interest Ratio & Short Volume

Tenax Therapeutics logo
$5.88 -0.08 (-1.26%)
As of 12:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Tenax Therapeutics Short Interest Data

Tenax Therapeutics (TENX) has a short interest of 337,000 shares, representing 9.28% of the float (the number of shares available for trading by the public). This marks a 8.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 15.4, indicating that it would take 15.4 days of the average trading volume of 160,664 shares to cover all short positions.

Current Short Interest
337,000 shares
Previous Short Interest
311,400 shares
Change Vs. Previous Month
+8.22%
Dollar Volume Sold Short
$1.94 million
Short Interest Ratio
15.4 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
4,150,000 shares
Float Size
3,630,000 shares
Short Percent of Float
9.28%
Today's Trading Volume
8,743 shares
Average Trading Volume
160,664 shares
Today's Volume Vs. Average
5%
Short Selling Tenax Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Tenax Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TENX Short Interest Over Time

TENX Days to Cover Over Time

TENX Percentage of Float Shorted Over Time

Tenax Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2025337,000 shares $1.94 million +8.2%9.3%15.4 $5.76
6/15/2025311,400 shares $1.77 million +0.3%8.6%14.6 $5.70
5/31/2025310,500 shares $1.94 million +0.1%8.6%19.3 $6.25
5/15/2025310,300 shares $1.77 million +0.7%8.6%13.3 $5.70
4/30/2025308,300 shares $1.78 million -8.3%8.5%9.3 $5.76
4/15/2025336,100 shares $1.87 million -7.8%9.3%9.2 $5.55
3/31/2025364,400 shares $2.39 million -2.4%10.5%9.4 $6.55
3/15/2025373,500 shares $2.39 million -2.2%11.3%8.7 $6.41
2/28/2025381,700 shares $2.27 million -9.0%11.5%7.8 $5.96
2/15/2025419,500 shares $3.02 million +93.1%14.1%8.4 $7.20
1/31/2025217,200 shares $1.30 million -2.6%7.3%3.9 $6.00
1/15/2025222,900 shares $1.44 million +2.2%7.5%3.5 $6.48
12/31/2024218,200 shares $1.35 million +6.7%7.3%3.3 $6.19
12/15/2024204,500 shares $1.20 million +56.6%6.9%3.3 $5.88
11/30/2024130,600 shares $700.02 thousand +8.0%4.4%2 $5.36
11/15/2024120,900 shares $588.78 thousand +14.3%4.1%2.3 $4.87
10/31/2024105,800 shares $464.46 thousand +403.8%3.6%1.9 $4.39
10/15/202421,000 shares $77.49 thousand -27.8%0.7%0 $3.69
9/30/202429,100 shares $100.69 thousand -42.2%1.0%0.1 $3.46
9/15/202450,300 shares $191.64 thousand -44.7%1.7%0.1 $3.81
8/31/202490,900 shares $362.69 thousand -21.6%3.1%0.2 $3.99
8/15/2024115,900 shares $463.60 thousand +1,014.4%4.6%0.2 $4.00
7/31/202410,400 shares $35.36 thousand -56.7%0.6%0 $3.40
7/15/202424,000 shares $80.64 thousand +103.4%1.3%1 $3.36
6/30/202411,800 shares $35.57 thousand +19.2%0.6%0.5 $3.01
6/15/20249,900 shares $31.09 thousand +54.7%0.5%0.3 $3.14
5/31/20246,400 shares $22.14 thousand -34.7%0.3%0.2 $3.46
5/15/20249,800 shares $35.18 thousand -56.3%0.5%0.1 $3.59
4/30/202422,400 shares $87.36 thousand -36.4%1.2%0.1 $3.90
4/15/202435,200 shares $126.90 thousand -28.2%1.9%0.1 $3.61
3/31/202449,000 shares $207.76 thousand +33.5%2.6%0.1 $4.24
3/15/202436,700 shares $137.63 thousand -49.4%2.2%0.1 $3.75
2/29/202472,500 shares $332.78 thousand +56.3%4.3%0.2 $4.59
2/15/202446,400 shares $194.42 thousand +30.7%2.8%0.2 $4.19
1/31/202435,500 shares $452.63 thousand +153.6%12.2%0.1 $12.75
1/15/202414,000 shares $199.36 thousand +833.3%4.8%0.2 $14.24
12/31/20231,500 shares $32.95 thousand -99.0%0.5%0 $21.97
12/15/2023155,600 shares $40.36 thousand -76.1%N/A0 $0.26
11/30/2023651,100 shares $227.23 thousand -78.1%N/A0.1 $0.35
11/15/20232,970,000 shares $1.48 million +16,308.8%N/A0.4 $0.50
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
10/31/202318,100 shares $3.36 thousand +43.7%N/A0 $0.19
10/15/202312,600 shares $3.97 thousand -84.9%N/A0 $0.32
9/30/202383,200 shares $24.88 thousand +263.3%N/A0.2 $0.30
9/15/202322,900 shares $7.79 thousand +114.0%N/A0 $0.34
8/31/202310,700 shares $3.74 thousand -69.4%N/A0 $0.35
8/15/202335,000 shares $10.49 thousand +1.2%N/A0 $0.30
7/31/202334,600 shares $10.90 thousand -73.7%N/A0 $0.32
7/15/2023131,400 shares $40.34 thousand -74.4%N/A0.2 $0.31
6/30/2023513,000 shares $153.90 thousand -10.3%N/A0.7 $0.30
6/15/2023572,000 shares $165.88 thousand +526.5%N/A0.6 $0.29
5/31/202391,300 shares $33.11 thousand -48.6%1.1%0 $0.36
5/15/2023177,600 shares $58.96 thousand -1.3%2.0%0.1 $0.33
4/30/2023179,900 shares $58.11 thousand -9.5%2.1%0.1 $0.32
4/15/2023198,800 shares $72.96 thousand -13.6%2.3%0 $0.37
3/31/2023230,000 shares $106.95 thousand -89.4%2.6%0.1 $0.47
3/15/20232,160,000 shares $1.23 million +387.7%24.8%0.6 $0.57
2/28/2023442,900 shares $301.17 thousand +21.9%6.3%0.2 $0.68
2/15/2023363,400 shares $339.74 thousand +306.9%5.2%0.4 $0.93
1/31/202389,300 shares $189.32 thousand -12.7%4.8%0.1 $2.12
1/15/2023102,300 shares $241.43 thousand +209.1%5.5%0.3 $2.36
12/30/202233,100 shares $3.69 thousand -94.4%1.8%0.1 $0.11
12/15/2022593,200 shares $78.24 thousand -57.9%N/A0.1 $0.13
11/30/20221,410,000 shares $208.68 thousand +260.4%N/A0.3 $0.15
11/15/2022391,200 shares $52.85 thousand +96.3%N/A0.1 $0.14
10/31/2022199,300 shares $26.29 thousand -4.4%17.2%0.1 $0.13
10/15/2022208,500 shares $30.96 thousand +43.4%18.0%0.4 $0.15
9/30/2022145,400 shares $24.72 thousand +146.0%12.5%0.3 $0.17
9/15/202259,100 shares $15.37 thousand -10.3%5.1%0.1 $0.26
8/31/202265,900 shares $15.75 thousand +1,120.4%5.7%0.3 $0.24
8/15/20225,400 shares $1.58 thousand -93.2%0.5%0 $0.29
7/31/202279,300 shares $20.94 thousand +539.5%6.8%0.4 $0.26
7/15/202212,400 shares $3.26 thousand -94.4%1.1%0.1 $0.26
6/30/2022222,600 shares $66.78 thousand +1,680.8%19.2%1.7 $0.30
6/15/202212,500 shares $7.63 thousand +5.0%1.1%0.1 $0.61
5/31/202211,900 shares $7.85 thousand -51.6%N/A0.4 $0.66
5/15/202224,600 shares $13.97 thousand +7.4%N/A0.7 $0.57
4/30/202222,900 shares $16.64 thousand -45.4%N/A0.6 $0.73
4/15/202241,900 shares $29.76 thousand +37.8%N/A0.9 $0.71
3/31/202230,400 shares $24.61 thousand -7.6%N/A0.5 $0.81
3/15/202232,900 shares $17.44 thousand +75.9%N/A0.2 $0.53
2/28/202218,700 shares $10.99 thousand -50.1%N/A0.1 $0.59
2/15/202237,500 shares $25.84 thousand -11.1%N/A0.2 $0.69
1/31/202242,200 shares $27.43 thousand -39.9%N/A0.3 $0.65
1/15/202270,200 shares $54.39 thousand -39.4%N/A0.4 $0.77
12/31/2021115,900 shares $120.54 thousand -25.9%N/A0.8 $1.04
12/15/2021156,300 shares $179.75 thousand -17.9%N/A1.9 $1.15
11/30/2021190,300 shares $243.58 thousand -25.7%N/A1.5 $1.28
11/15/2021256,100 shares $355.98 thousand -2.9%N/A2.1 $1.39
10/29/2021263,600 shares $400.67 thousand -13.2%N/A2.2 $1.52
10/15/2021303,800 shares $525.57 thousand +29.5%N/A2.5 $1.73
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
9/30/2021234,600 shares $415.24 thousand +32.2%N/A2 $1.77
9/15/2021177,400 shares $244.81 thousand +20.0%N/A1.5 $1.38
8/31/2021147,800 shares $235.00 thousand -0.5%N/A1.3 $1.59
8/13/2021148,500 shares $233.15 thousand -8.7%N/A1.2 $1.57
7/30/2021162,700 shares $281.47 thousand -23.2%1.5%1.3 $1.73
7/15/2021211,900 shares $398.37 thousand +12.2%2.0%1.5 $1.88
6/30/2021188,900 shares $392.91 thousand +14.6%2.9%0.9 $2.08
6/15/2021164,800 shares $342.78 thousand -8.1%2.6%0.1 $2.08
5/28/2021179,400 shares $349.83 thousand -32.0%1.3%0.1 $1.95
5/14/2021263,700 shares $530.04 thousand -31.6%N/A0.2 $2.01
4/30/2021385,700 shares $752.12 thousand -50.8%N/A0.3 $1.95
4/15/2021783,300 shares $1.59 million +64.9%N/A0.5 $2.03
3/31/2021475,100 shares $897.94 thousand -1.3%N/A0.2 $1.89
3/15/2021481,400 shares $1.07 million -15.5%N/A0.1 $2.22
2/26/2021569,400 shares $1.27 million -1.2%N/A0.1 $2.23
2/12/2021576,100 shares $1.61 million -10.0%N/A0.1 $2.79
1/29/2021640,100 shares $1.47 million +325.9%N/A0.1 $2.30
1/15/2021150,300 shares $267.53 thousand -95.9%N/A0 $1.78
12/31/20203,630,000 shares $7.19 million +12,331.5%N/A0.9 $1.98
12/15/202029,200 shares $31.83 thousand -13.9%N/A0.2 $1.09
11/30/202033,900 shares $37.96 thousand +27.0%N/A0.2 $1.12
11/15/202026,700 shares $28.87 thousand -65.3%N/A0.1 $1.08
10/30/202077,000 shares $85.47 thousand -52.1%N/A0.4 $1.11
10/15/2020160,700 shares $199.27 thousand -28.0%N/A0.7 $1.24
9/30/2020223,300 shares $343.88 thousand +58.4%N/A0.7 $1.54
9/15/2020141,000 shares $229.83 thousand -18.8%N/A0.4 $1.63
8/31/2020173,600 shares $248.25 thousand +60.0%N/A0.5 $1.43
8/14/2020108,500 shares $138.88 thousand +83.3%N/A0.1 $1.28
7/31/202059,200 shares $78.74 thousand +187.4%N/A0 $1.33

TENX Short Interest - Frequently Asked Questions

What is Tenax Therapeutics' current short interest?

Short interest is the volume of Tenax Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 337,000 shares of TENX short. 9.28% of Tenax Therapeutics' shares are currently sold short. Learn More on Tenax Therapeutics' current short interest.

What is a good short interest ratio for Tenax Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TENX shares currently have a short interest ratio of 15.0. Learn More on Tenax Therapeutics's short interest ratio.

What is a good short interest percentage for Tenax Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.28% of Tenax Therapeutics' floating shares are currently sold short.

Is Tenax Therapeutics' short interest increasing or decreasing?

Tenax Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 337,000 shares, an increase of 8.2% from the previous total of 311,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tenax Therapeutics' float size?

Tenax Therapeutics currently has issued a total of 4,150,000 shares. Some of Tenax Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenax Therapeutics currently has a public float of 3,630,000 shares.

How does Tenax Therapeutics' short interest compare to its competitors?

9.28% of Tenax Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tenax Therapeutics: Corbus Pharmaceuticals Holdings, Inc. (14.39%), OKYO Pharma Limited Sponsored ADR (0.51%), Coherus Oncology, Inc. (29.97%), MacroGenics, Inc. (7.80%), OncoCyte Corporation (1.32%), Zentalis Pharmaceuticals, Inc. (10.61%), Forte Biosciences, Inc. (1.38%), BeyondSpring Inc. (7.23%), Oramed Pharmaceuticals Inc. (1.19%), Invivyd, Inc. (6.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Tenax Therapeutics stock?

Short selling TENX is an investing strategy that aims to generate trading profit from Tenax Therapeutics as its price is falling. TENX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tenax Therapeutics?

A short squeeze for Tenax Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TENX, which in turn drives the price of the stock up even further.

How often is Tenax Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TENX, twice per month. The most recent reporting period available is June, 30 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:TENX) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
Interactive Offers | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Central Banks Are Hoarding Gold – Should You?
The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...
Lear Capital | Sponsored
Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...
Weiss Ratings | Sponsored
All New Social Security Numbers coming July 23?
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
"Death Spiral" Threatening Your Savings
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
GoldCo Precious Metals | Sponsored